To afford a dividend, companies must make consistent profits, preferably via a business model that won't need to change significantly over time. That means they're often priced at a premium because investors love consistency, as they well should.

But sometimes, a window of opportunity opens to load up on certain dividend stocks before their valuations get bloated, as they tend to do during a bull market. Here are two such stocks with that window still wide open, even if it might not be for much longer.

If you want to capture the juicy forward dividend yield of above 4% from holding shares of Viatris (NASDAQ: VTRS), it'll behoove you to invest soon. The company's portfolio of generic medicines is always expanding. It's currently waiting on regulatory approval to commercialize at least 10 new generics for complex injectable drugs, which could add more than $1 billion in sales to its top line before 2027. Given that its trailing-12-month (TTM) sales are $16.7 billion and that it has a smorgasbord of other approvals in the pipeline, anticipated to generate at least another $2 billion in annual revenue by 2028, its shares are likely to rise in the coming years.

Continue reading

Source Fool.com